Nektar Therapeutics (NKTR)

55.31 +4.19 (+8.20%) USD  |  NASDAQ  |  Dec 12, 15:14
More

Nektar Therapeutics Total Operating Expenses (Quarterly)

Total Operating Expenses (Quarterly) Chart

View Total Operating Expenses (Quarterly) for NKTR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (Quarterly) Range, Past 5 Years

View Total Operating Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (Quarterly) Benchmarks

View Total Operating Expenses (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Amicus Therapeutics, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Rigel Pharmaceuticals, Inc. Upgrade
Zevra Therapeutics, Inc. Upgrade